Author:
Punnoose Elizabeth A.,Atwal Siminder K.,Spoerke Jill M.,Savage Heidi,Pandita Ajay,Yeh Ru-Fang,Pirzkall Andrea,Fine Bernard M.,Amler Lukas C.,Chen Daniel S.,Lackner Mark R.
Publisher
Public Library of Science (PLoS)
Reference55 articles.
1. Prospects for personalized medicine with inhibitors targeting the RAS and PI3K pathways.;MR Lackner;Expert Rev Mol Diagn,2010
2. Biomarker-driven early clinical trials in oncology: a paradigm shift in drug development.;DS Tan;Cancer J,2009
3. Can molecular biomarker-based patient selection in Phase I trials accelerate anticancer drug development?;CP Carden;Drug Discov Today,2009
4. Molecular Mechanisms of Resistant to Cetuximab and Panitumumab in Colorectal Cancer.;A Bardelli;Journal of Clinical Oncology,2010
5. Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer.;CL Vogel;J Clin Oncol,2002
Cited by
252 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献